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Tonic GABAergic inhibition regulates neuronal excitability and has been implicated to be
involved in both neurological and psychiatric diseases. We have previously shown that the
endogenous peptide antisecretory factor (AF) decreases phasic GABAergic inhibition onto
pyramidal CA1 neurons. In the present study, using whole-cell patch-clamp recordings, we
investigated the mechanisms behind this disinhibition of CA1 pyramidal neurons by AF.
We found that application of AF to acute rat hippocampal slices resulted in a reduction of
the frequency, but not of the amplitude, of spontaneous inhibitory postsynaptic currents
(sIPSCs) in CA1 pyramidal neurons. Miniature inhibitory postsynaptic currents (mIPSCs),
recorded in the presence of tetrodotoxin (TTX), were however not affected by AF, neither in
CA1 pyramidal cells, nor in stratum radiatum interneurons. Instead, AF caused an increase
of the tonic GABAA current in stratum radiatum interneurons, leaving the tonic GABAergic
transmission in CA1 pyramidal cells unaffected. These results show that the endogenous
peptide AF enhances tonic, but not phasic, GABAergic signaling in CA1 stratum radiatum
interneurons, without affecting tonic GABAergic signaling in CA1 pyramidal neurons. We
suggest that this increased tonic GABAergic signaling in GABAergic interneurons could be
a mechanism for the AF-mediated disinhibition of pyramidal neurons.
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INTRODUCTION
Antisecretory factor (AF) is an endogenous 43 kDa protein that
is expressed in all mammalian tissues and plasma investigated so
far (Johansson et al., 1995, 2009; Lange et al., 1999; Lange and
Lönnroth, 2001; Ulgheri et al., 2010). The protein was named AF
due to its capacity to counteract enterotoxin-induced intestinal
hypersecretion, but later studies have shown that AF is also a
potent anti-inflammatory agent (Johansson et al., 1997a, 2013;
Eriksson et al., 2003; Davidson and Hickey, 2004a,b; Graber et al.,
2011; Mane et al., 2011). Protein AF, which is also named S5a
or RPn10, is a component of the 26S proteasome (Ulgheri et al.,
2010). It can either be associated to the proteasome, or appear in a
free form. This free form appears to have functions not associated
with the proteasome.
The “active site” of AF, i.e., the part of the AF protein which
effectuates the anti-secretory and anti-inflammatory action, can
be isolated to an eight amino acid long sequence at the N-terminal
part of the protein, IVCHSKTR (Johansson et al., 1997b). A some-
what larger peptide, AF-16, also including the active sequence,
is more stable and therefore acceptable for experimental work
(Jennische et al., 2008). AF has been demonstrated to counteract
various forms of intestinal hypersecretion in clinical studies, and
a number of experimental studies have demonstrated a protective,
regulating effect of AF-16 in various models of tissue injury.
Thus, AF-16 normalized the intracranial pressure and abolished
mortality in rats with experimental herpes simplex 1 encephalitis
(Jennische et al., 2008), while a high endogenous level of plasma
AF prevented a rise in intracranial pressure and improved the
cognitive functions in rats exposed to focal brain injury (Säljö
et al., 2010). In a mouse colitis model treatment with AF decreased
the extent of inflammation even in a late phase of the disease
(Mane et al., 2011). Furthermore, the endogenous level of AF
varies between mice strains. Thus, strains with a high AF mRNA
expression are more resistant to autoimmune encephalitis than
strains with a lower AF mRNA expression (Davidson and Hickey,
2004a). Taken together, the results of these studies suggest that
the major effect of AF is to regulate/modulate hypersecretion and
inflammatory reactions. The cellular mechanisms that mediate
these anti-inflammatory and anti-secretory effects by AF are,
however, largely unknown.
We have previously shown in vitro that AF-16 affects neuronal
signaling in the brain (Kim et al., 2005). Specifically, application
of AF-16 to acute rat hippocampal slices reduces GABAergic
transmission onto CA1 pyramidal cells without affecting gluta-
matergic transmission. This disinhibitory effect was mimicked
by feeding the rats with a diet containing hydrothermally pro-
cessed cereals and by per oral administration of cholera toxin. In
the present study we have investigated mechanisms behind this
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suppression of GABAergic transmission. We found that AF-16
enhances the tonic GABAergic current in CA1 stratum radiatum
interneurons, without affecting the tonic GABAergic current in
CA1 pyramidal neurons. We propose that the increased tonic
GABAergic signaling in the GABAergic interneurons contributes




Hippocampal transverse slices (300–400µm thick) were prepared
from male P38–P60 Wistar rats, however in the experiments
illustrated in Figure 6 both Wistar and Sprauge-Dawley rats were
used. There was no difference in the effect of AF-16 between
the two strains (see Section Results). Rats were anesthetized with
isoflurane prior to decapitation using a guillotine. After decapi-
tation the skull was opened and the brain hemispheres were put
in a 4◦C solution containing (in mM): 110 cholineCl, 2.5 KCl,
1.25 NaH2PO4, 25 NaHCO3, 0.5 CaCl2, 7 MgCl2, 1.3 ascorbic
acid and 7 D-glucose. Hippocampal slices were prepared using
a vibratome (Microtome HM 650 V, Thermo Fisher Scientific,
Loughborough, UK) in the same solution as above and then trans-
ferred to a storage chamber with a 25◦C artificial cerebrospinal
fluid (ACSF) containing (in mM): 1.25 NaH2PO4, 124 NaCl,
26 NaHCO3, 3 KCl, 4 MgCl2, 2 CaCl2, 5 ascorbic acid, 4 D,L-
lactic acid, 3 myo-inositol and 10 D-glucose. For experiments
where slices were incubated in AF-16 the storage solution also
contained 0.5µg/ml AF-16 (this concentration of AF-16 was used
in all experiments of this study). The slices were kept in the
storage solution for 1–6 h before being transferred to the record-
ing chamber. In the recording chamber the slices were perfused
(2–3 ml/min) with ACSF containing (in mM): 1.25 NaH2PO4,
124 NaCl, 26 NaHCO3, 3 KCl, 2 MgCl2, 2 CaCl2 and 10 D-
glucose. The perfusion ACSF also contained AF-16 in experiments
where slices had been incubated in AF-16. All solutions were
continuously bubbled with gas containing 95% O2 and 5% CO2
(pH 7.4) (AGA Gas AB, Lidingö, Sweden).
RECORDING AND ANALYSIS
CA1 pyramidal cells and stratum radiatum interneurons were
visually identified using infrared differential interference contrast
video microscopy mounted on an Olympus BX51WI micro-
scope. Whole-cell patch-clamp recordings were performed with
a patch clamp amplifier (EPC-9, Heka Elektronik, Lambrecht,
Germany) at a sampling frequency of 10 kHz and filtered at
2.9 kHz. To record GABAA receptor-mediated responses the
neurons were voltage clamped at 0 mV and the pipette solution
contained (in mM): 130 Cs-methanesulfonate, 2 NaCl, 10 HEPES,
0.6 EGTA, 5 Qx-314, 4 Mg-ATP and 0.4 GTP (pH 7.3, adjusted
with D-gluconic acid). Patch pipettes (borosilicate, OD 1.5 mm,
ID 0.86 mm) were pulled with a horizontal Flaming/Brown
micropipette puller (P-97, Sutter Instrument Company, Novato,
CA, USA) and they had a resistance of 2.8–6.6 M. Series
resistance was monitored using a 5 or 10 mV hyperpolarizing
pulse and was not allowed to change more than 20%. All record-
ings were performed at room temperature. Analysis of minia-
ture inhibitory postsynpatic currents (mIPSCs) and spontaneous
IPSCs (sIPSCs) was performed using the Mini Analysis Program
(version 5.6.28, Synaptosoft Inc, Fort Lee, NJ, USA). The first
100 miniature/spontaneous events at every given time point were
analyzed. The cumulative plots shown in the figures were made
from averaging the individual cumulative plots based on the nor-
malized values from the time points indicated. Input resistance
and holding current were measured using custom made software
in Igor Pro (WaveMetrics Inc, Lake Oswego, OR, USA). The input
resistance was measured using a hyperpolarizing pulse of 5 or
10 mV for 200–500 ms. Picrotoxin (PTX) (100 µM) was used
to block GABAA receptor mediated currents. The voltage-gated
sodium channel blocker tetrodotoxin (TTX) (1 µM) was used to
block action potentials when recording mIPSCs.
STATISTICS
All data are expressed as means ± standard error of the mean.
Statistical significance was evaluated using Student’s t-test for
paired or independent data and Kolmogorov-Smirnov test for
distributions.
DRUGS AND CHEMICALS
Chemicals were from Sigma-Aldrich (Steinheim, Germany) and
Merck (Damstadt, Germany) except for TTX (Abcam Biochem-
icals, Cambridge, UK and Alomone labs, Jerusalem, Israel). The
AF-16 peptide (VCHSK TRSNP ENNVG L) and the scram-
bled AF-16 peptide (GRSNK VENCL PHNST V) were synthe-
sized with solid phase synthesis (Ross-Petersen AS, Copenhagen,
Denmark).
RESULTS
ANTISECRETORY FACTOR (AF-16) REDUCES THE FREQUENCY OF
SPONTANEOUS INHIBITORY POSTSYNAPTIC CURRENTS (IPSCs) ONTO
CA1 PYRAMIDAL NEURONS
We have previously shown, using extracellular field recordings,
that AF-16 reduced evoked feed-forward GABAergic inhibition
onto CA1 pyramidal neurons (Kim et al., 2005). In the present
study, using whole-cell patch clamp recordings, we further exam-
ined the effect of AF-16 on GABAergic inhibition onto CA1
pyramidal neurons. We first investigated spontaneous action
potential-dependent sIPSCs in CA1 pyramidal neurons. 50–60
min after applying AF-16 to the hippocampal slice there was a
decrease in the frequency of sIPSCs to 78 ± 7% (p < 0.05, paired
t-test) of the frequency obtained prior to the application, without
a significant change in the averaged amplitude 95± 7% (p = 0.52,
paired t-test) of the sIPSCs (n = 8) (Figure 1A). As described
previously (Kim et al., 2005), the effect of AF-16 on GABAergic
transmission developed slowly over more than 30 min. There was
no run-down of phasic GABAergic signaling (in the presence of
TTX) in control experiments (Figures 2C, D). In parallel with
the average change in sIPSC frequency, the averaged cumulative
distribution of sIPSC inter-event intervals before and 60 min after
AF-application was significantly altered (Figure 1B) (p < 0.05,
Kolmogorov-Smirnov test). The averaged cumulative distribution
of sIPSC amplitudes was not significantly altered (Figure 1C) (p =
0.92, Kolmogorov-Smirnov test). This result confirms previous
results (Kim et al., 2005) showing a disinhibitory effect of AF.
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FIGURE 1 | AF-16 reduces the frequency of sIPSCs in CA1
pyramidal neurons. (A) Summary graph of average (± s.e.m.)
frequencies and amplitudes of recorded sIPSCs in CA1 pyramidal
neurons (n = 8) during application of AF-16. Representative traces
from time points a (orange trace before the application of AF) and b
(dark brown trace 60 min after the application of AF) are shown at
the top, scale bar represents 40 pA and 1 s. (B) Effect of AF-16 on
the cumulative distribution of sIPSC inter-event intervals (n = 8).
(C) Effect of AF-16 on the cumulative distribution of sIPSC amplitudes
(n = 8).
ANTISECRETORY FACTOR (AF-16) DOES NOT ALTER MINIATURE
INHIBITORY POSTSYNAPTIC CURRENT (mIPSC) AMPLITUDE OR
FREQUENCY ONTO CA1 PYRAMIDAL CELLS
To further investigate the reduced GABAergic inhibition onto
CA1 pyramidal cells we examined the effect of AF-16 on spon-
taneous action potential-independent mIPSCs in CA1 pyramidal
neurons. In the presence of 1 µM TTX, blocking all action
potentials, we measured mIPSC frequency and amplitude before
and 60 min after application of AF-16 (Figure 2). Application
of AF-16 to the hippocampal slice had no significant effect on
mIPSC frequency or amplitude (Figures 2A, B). The averaged
frequency and amplitude of mIPCSs 60 min following application
of AF-16 were 101 ± 4% and 101 ± 4%, respectively (n =
6), compared to before application of AF-16. To control for
unspecific changes during whole-cell recordings we also measured
mIPSC frequency and amplitude in control experiments without
drug application (Figures 2B–D). The average frequency and
amplitude of the mIPSCs were not significantly changed over
60 min in these experiments (99± 5% and 96± 4%, respectively,
n = 7). The averaged cumulative distributions of inter-event
intervals and amplitudes of mIPSCs before and 60 min after
AF-application and corresponding controls were not significantly
altered (Figures 2E, F) (AF: p = 0.99 for inter-event intervals
and p = 0.98 for amplitudes, controls: p = 0.85 for inter-event
intervals and p = 0.78 for amplitudes, Kolmogorov-Smirnov test).
Taken together, AF-16 reduces the frequency of sIPSCs in CA1
pyramidal neurons without changing the frequency or amplitude
of mIPSCs.
ANTISECRETORY FACTOR (AF-16) ENHANCES THE TONIC, BUT NOT
PHASIC, GABAA RECEPTOR-MEDIATED CURRENT IN CA1 STRATUM
RADIATUM INTERNEURONS
Most of the GABAergic inhibitory synaptic contacts onto CA1
pyramidal neurons are from local interneurons in the CA1 stra-
tum radiatum (Klausberger, 2009; Bezaire and Soltesz, 2013).
Since AF-16 decreased the frequency of action potential depen-
dent sIPSCs, but not mIPSCs, onto CA1 pyramidal cells we spec-
ulated that the effect of AF-16 on GABAergic transmission could
be due to a lowering of the intrinsic excitability of the interneu-
rons making them less likely to signal onto the pyramidal cells.
Increasing the tonic GABAergic current in the interneurons is one
possible mechanism that could result in such a lowering of their
intrinsic excitability. We therefore measured the tonic GABAA
receptor-mediated current in stratum radiatum interneurons by
recording the change in holding current and input resistance
after application of the GABAA receptor channel blocker PTX in
control slices and in slices that had been incubated in AF-16 for
>1 h before measuring. Slices incubated in AF-16 had a larger
tonic GABAA receptor-mediated transmission both measured as
the change in holding current (AF-16: 9.6 ± 1.4 pA, n = 8,
compared to control: 0.9 ± 0.8 pA, n = 5, p < 0.001, unpaired
t-test; Figure 3A) and measured as the change in input resistance
(AF-16: 16± 4%, n = 8, compared to control:−4± 8%, n = 5, p<
0.05, unpaired t-test) (Figure 3B) after PTX application. A tonic
GABAA receptor-mediated transmission could be measured in all
of the interneurons incubated in AF-16 (Figures 3A, B). As the
effect of AF-16 on GABAergic transmission onto CA1 pyramidal
Frontiers in Cellular Neuroscience www.frontiersin.org January 2014 | Volume 8 | Article 13 | 3
Strandberg et al. Antisecretory factor promotes tonic inhibition
FIGURE 2 | No effect of AF-16 on mIPSCs in CA1 pyramidal neurons.
(A) Representative traces from time points a (orange trace before the
application of AF) and b (dark brown trace 60 min after the application of
AF) in (C) and (D) from an experiment with application of AF-16, scale bar
represents 20 pA and 100 ms. (B) Representative traces from time points
a (green trace at time “0 min”) and b (dark green at time “60 min”) in (C)
and (D) from a control experiment without application of AF-16, scale bar
represents 20 pA and 100 ms. (C) Summary graph of average (± s.e.m.)
frequencies of recorded mIPSCs in CA1 pyramidal neurons exposed to
AF-16 (n = 6) and controls not exposed to AF-16 (n = 7). (D) Summary
graph of average (± s.e.m.) amplitudes of recorded mIPSCs in CA1
pyramidal neurons exposed to AF-16 (n = 6) and controls (n = 7).
(E) Cumulative distributions of mIPSC inter-event intervals at 0 min and
60 min after AF-16 application (n = 6) and control (n = 7). (F) Cumulative
distributions of mIPSC amplitudes at 0 min and 60 min after AF-16
application (n = 6) and control (n = 7).
cells develops slowly over more than 30 min, we also wanted to
measure how the effect of AF-16 on tonic GABAergic transmis-
sion in CA1 stratum radiatum interneurons develops over time.
We measured the effect of AF-16 as the change in input resistance
over 60 min after application of AF-16 to the ACSF. 60 min after
the application of AF-16 the input resistance had decreased by
−22 ± 6% (n = 8) (Figure 4A), significantly different from the
observed effect on the input resistance by a scrambled AF-16
peptide (6± 7%, n = 8, p< 0.05, unpaired t-test) (Figure 4B).
These results show that AF causes an increased tonic
GABAergic signaling onto GABAergic interneurons. We next
wanted to examine whether phasic GABAergic inhibition onto
these interneurons was affected by AF. We therefore recorded
mIPSCs in stratum radiatum interneurons before and after
the application of AF-16. As can be seen in Figure 5A there
was no significant change in the frequency (105 ± 5%) or
the amplitude (101 ± 5%) of mIPSCs 50–60 min following
application of AF-16 (n = 6). The averaged cumulative dis-
tributions of inter-event intervals and amplitudes of mIPSCs
before and 60 min after AF-application were not significantly
altered (Figures 5B, C) (p = 0.99 and p = 0.99, respectively,
Kolmogorov-Smirnov test). These results thus indicate that AF
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FIGURE 3 | AF-16 enhances tonic GABAergic transmission in CA1
stratum radiatum interneurons. (A) Diagram showing the effect of PTX
on the holding current in CA1 stratum radiatum interneurons incubated in
AF-16 (n = 8) and control (n = 5). Open circles represent the individual
experiments while the filled circles represent the average (± s.e.m.) values.
On the left are representative traces before and after application of PTX,
scale bar represents 10 pA and 250 ms. (B) Diagram showing the effect of
PTX on the input resistance in CA1 stratum radiatum interneurons
incubated in AF-16 (n = 8) and control (n = 5). Open circles represent the
individual experiments while the filled circles represent the average
(± s.e.m.) values. On the left are representative traces during a −10 mV
test pulse before (orange/light orange and green/light green colors for AF
and control, respectively) and after (dark brown/gray and dark green/gray
colors for AF and control, respectively) application of PTX, scale bar
represents 30 pA and 75 ms. * p < 0.05, *** p < 0.001.
enhances tonic, but not phasic, GABAergic inhibition onto these
interneurons.
THE TONIC GABAA RECEPTOR-MEDIATED CURRENT IN CA1
PYRAMIDAL CELLS IS NOT ALTERED BY ANTISECRETORY FACTOR
(AF-16)
The change in tonic GABAergic transmission onto interneurons
could depend on a change in the expression levels or kinetics of
the GABA receptors, but it could also depend on an increased level
of ambient GABA (Jensen et al., 2003; Glykys and Mody, 2007;
Song et al., 2013). An increased level of ambient GABA is expected
to also enhance the tonic GABAergic transmission in pyramidal
neurons. We therefore measured the effect of AF-16 on the tonic
GABAA receptor-mediated current in CA1 pyramidal neurons.
By using the same analytical approach used to measure the tonic
GABAA receptor-mediated tonic current in the interneurons, AF-
16 did not significantly alter the change in holding current (AF-
16: 12 ± 1.5 pA, n = 7, compared to control: 15 ± 1.6 pA, n = 9,
p = 0.22, paired t-test) (Figure 6A) or in input resistance (AF-16:
16 ± 5%, n = 5, compared to control: 15 ± 2%, n = 8, p = 0.74,
paired t-test) (Figure 6B) after PTX application. In this specific set
of experiments both Wistar and Sprague-Dawley rats were used.
FIGURE 4 | AF-16 reduces the input resistance in CA1 stratum
radiatum interneurons. (A) Summary graph of average (± s.e.m.) input
resistance during application of AF-16 in CA1 stratum radiatum interneurons
(n = 8). Representative traces from time points a (orange/light orange
colors) and b (dark brown/gray colors) are shown inside the graph, scale bar
represents 30 pA and 75 ms. (B) Summary graph of average (± s.e.m.)
input resistance during application of scrambled AF-16 in CA1 stratum
radiatum interneurons (n = 8). Representative traces from time points a
(green/light green colors) and b (dark green/gray colors) are shown inside
the graph , scale bar represents 30 pA and 75 ms.
The results were pooled since there was no significant difference
between the two strains (changes in holding current after PTX
applications were: 12.8 ± 1.8 pA, n = 4 in Wistar AF-16 treated
compared to 11.2 ± 3.1 pA, n = 3 in Sprague Dawley AF-16
treated, p = 0.65 (independent samples t-test) and 14.1 ± 1.7 pA,
n = 7 in Wistar control compared to 18.4 ± 4.3 pA, n = 2 in
Sprague Dawley control, p = 0.29 (independent samples t-test)).
DISCUSSION
In the present study we have investigated how the endogenous
peptide AF affects GABAergic transmission onto pyramidal neu-
rons and stratum radiatum GABAergic interneurons in the hip-
pocampus. In pyramidal neurons we found that AF causes a
reduction in the frequency of action potential-dependent, but not
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FIGURE 5 | No effect of AF-16 on mIPSCs in CA1 stratum radiatum
interneurons. (A) Summary graph of average (± s.e.m.) frequencies
and amplitudes of recorded mIPSCs in CA1 stratum radiatum
interneurons (n = 6) during application of AF-16. Representative traces
from time points a (orange trace before the application of AF) and b
(dark brown trace 60 min after the application of AF) are shown at
the top, scale bar represents 20 pA and 100 ms. (B) Effect of AF-16
on the cumulative distribution of mIPSC inter-event intervals (n = 6).
(C) Effect of AF-16 on the cumulative distribution of mIPSC
amplitudes (n = 6).
of action potential-independent, spontaneous IPSCs, and that AF
did not affect the tonic GABAergic transmission. In interneu-
rons, on the other hand, we found that AF enhances the cur-
rents through tonically active GABAA receptors. Phasic GABAA
receptor-mediated synaptic transmission onto the interneurons,
as measured as mIPSCs, was not affected. We thus identify AF
as positive neuromodulator of tonic GABAergic signaling specifi-
cally on GABAergic interneurons.
We propose that the increase of the tonically active GABAA
receptor-mediated current, induced by AF, results in a decreased
excitability of the interneurons. It is however not obvious that
an increased tonic GABA current results in decreased excitability
since GABAergic interneurons, in contrast to pyramidal neurons,
do not exhibit a developmental shift from a depolarizing to a
hyperpolarizing reversal potential for GABAA receptor-mediated
currents (Banke and Mcbain, 2006). More specifically, stratum
radiatum interneurons have been shown to exhibit a reversal
potential for tonic GABAA receptor-mediated currents (−62 mV)
that is more depolarized than the resting membrane potential
(−72 mV), but more hyperpolarized than the threshold for
action potential (−44 mV) (Song et al., 2011). Song et al. (2011)
further showed that a low increase of the GABAA conductance
can actually increase the excitability of these interneurons (via
a depolarization), whereas a larger increase of the GABAA con-
ductance results in a decreased excitation (when the shunting
currents overrides the depolarization). Our findings suggest that
the AF-induced increase of the tonic GABAA receptor-mediated
current results in a decreased interneuronal excitability. Impor-
tantly, application of AF resulted in a reduced, not increased,
frequency of spontaneous, action-potential dependent, IPSCs in
CA1 pyramidal neurons. This result is also consistent with our
previously reported reduction of evoked feed-forward inhibition
in CA1 pyramidal neurons (Kim et al., 2005). Moreover, the
temporal development of the enhanced tonic GABAA receptor
currents in the interneurons paralleled that of the decreased
evoked (Kim et al., 2005), and spontaneous (Figure 1), inhibitory
synaptic activity onto the CA1 pyramidal neurons.
In the present study we have not examined the mechanisms by
which AF increases the tonic GABAA receptor-mediated current
in the stratum radiatum interneurons. We envision two main,
non-exclusive, possible mechanisms: an increased concentration
of ambient GABA, or more functionally active extrasynaptic
GABAA receptors. An increased concentration of ambient GABA,
produced by, for example, inhibition of GABA transporters, seems
unlikely since we did not find any enhancement of the tonic
GABAergic current in CA1 pyramidal neurons. It can be noted
that tonic GABAergic currents may be difficult to detect in CA1
pyramidal neurons because of prominent outward rectification
(Pavlov et al., 2009). In this study we have, however, recorded
GABAergic currents at 0 mV (using a low intracellular chloride
concentration), and we observed prominent tonic GABAergic
currents in the CA1 pyramidal neurons, but no enhancement by
AF. We did not find any significant tonic GABAergic signaling
in the GABAergic interneurons under baseline conditions. This
discrepancy between our finding and that reported by others
(Semyanov et al., 2003; Scimemi et al., 2005; Song et al., 2013)
seems to be quantitative rather than qualitative. Indeed there are
other reports of non-significant tonic GABAergic signaling in
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FIGURE 6 | AF-16 does not enhance tonic GABAergic transmission in
CA1 pyramidal neurons. (A) Diagram showing the effect of PTX on the
holding current in CA1 pyramidal neurons incubated in AF-16 (n = 7) and
control (n = 9). Open circles represent the individual experiments while the
filled circles represent the average (± s.e.m.) values. On the left are
representative traces before and after application of PTX, scale bar
represents 10 pA and 250 ms. (B) Diagram showing the effect of PTX on
the input resistance in CA1 pyramidal neurons incubated in AF-16 (n = 5)
and control (n = 8). Open circles represent the individual experiments while
the filled circles represent the average (± s.e.m.) values. On the left are
representative traces during a −5 mV test pulse before (orange/light orange
and green/light green colors for AF and control, respectively) and after (dark
brown/gray and dark green/gray colors for AF and control, respectively)
application of PTX, scale bar represents 30 pA and 75 ms. n.s. not
significant (p > 0.05).
interneurons in the CA1 region (Bieda and Maciver, 2004), as
well as in somatostatin-positive interneurons in layer 2/3 of the
frontoparietal cortex (Vardya et al., 2008). It appears that this dif-
ference relates to differential basal conditions including different
strains, gender and age of the animals used (Marchionni et al.,
2007).
In CA1 pyramidal neurons tonic GABAergic signaling is medi-
ated mainly via α5-containing GABAA receptors, whereas δ-
containing GABAA receptors mediate tonic GABAergic signaling
in dentate granule cells and many GABAergic interneurons (Gao
and Fritschy, 1994; Sperk et al., 1997; Glykys et al., 2008; Mann
and Mody, 2010; Ferando and Mody, 2012). A differential mod-
ulation of tonic GABAergic signaling mediated by different types
of GABAA receptors has previously been reported (Glykys et al.,
2007; Jin et al., 2011; Tao et al., 2013). It is thus possible that
the presently found differential effect of AF on tonic GABAergic
signaling could be explained by a selective increase in the number
and/or efficacy of extrasynaptic GABAA receptors in GABAer-
gic interneurons that normally express δ-containing GABAA
receptors. Such an increase of extrasynaptic GABAA receptors
could be mediated by exocytosis and membrane insertion of
GABAA receptors (Saliba et al., 2012). We note, however, that the
AF-induced increase of tonic GABAergic signaling in the
interneurons develops over tens of minutes, indicating that the
putative exocytosis might include synthesis of new receptors. It is
also important to note that the proposed AF-induced membrane
insertion of new GABA receptors is exclusive for the extrasynaptic
membrane since AF did not induce any increase of the mIPSC
amplitude in the GABAergic interneurons, or in the CA1 pyrami-
dal neurons. Our study thus adds to the concept of differential
modulation of phasic and tonic GABAergic signaling. It also
adds to the emerging concept of differential modulation of tonic
GABAergic signaling in different types of neurons. Since the
modulation by different neuromodulators likely differs with gen-
der, age, species, strain, etc, the emerging concept of differential
modulation may also help to explain the reported variation in
tonic GABAergic signaling in different studies.
In the CA1 region the interneurons can be divided into dif-
ferent groups based on location, morphology, physiological and
molecular features (Ascoli et al., 2008; Klausberger and Somogyi,
2008). The cell bodies of the interneurons in the CA1 region
are located in stratum radiatum as well as stratum lacunosum-
moleculare, pyramidale and oriens. In the present study we only
investigated interneurons with their cell bodies located in the
stratum radiatum, with no further characterization. This selection
likely includes cholecystokinin-positive Schaffer-collateral associ-
ated and apical dendrite innervating interneurons, but excludes
parvalbumin-positive interneurons (Klausberger and Somogyi,
2008). We therefore do not know if our findings also apply to
interneurons located in other parts of the CA1 region. However,
all the interneurons investigated displayed similar effects elicited
by AF. Moreover, the about 20% reduction in the frequency of
sIPSCs in CA1 pyramidal neurons by AF (Figure 1) is similar
to the reduction of evoked feed-forward inhibition (Kim et al.,
2005), suggesting that the presently described effect of AF may be
general among hippocampal interneurons.
The modulation of interneuronal extrasynaptic GABAA recep-
tors by AF adds to the concept that extrasynaptic GABAA recep-
tors are an important target for neuromodulation (Garcia et al.,
2010; Jin et al., 2011; Ferando and Mody, 2012; Tao et al., 2013).
GABAA receptors are however not only expressed on neurons in
the central nervous system, but also in the enteric nervous system
(Krantis, 2000), as well as on non-neuronal cells such as immune
cells (Bjurstom et al., 2008) and endocrine pancreatic cells (Jin
et al., 2013). Dysregulation of GABAA receptors on these cells
has been implicated in immunological disorders (Bjurstom et al.,
2008) and diabetes (Taneera et al., 2012). The cellular mechanisms
behind AF’s anti-inflammatory and antisecretory effects have not
been established, but our present results suggest the possibility
that one such cellular mechanism is mediated via a positive
modulation of GABAA receptors on certain neuronal and non-
neuronal cells.
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